Findings indicate blood group A elevates the risk of primary biliary cholangitis, suggesting ABO group analysis could aid in ...

ABO-101 is Abeona's second AAV gene therapy to commence clinical trials in a rare CNS disease The clinical trial is a Phase 1/2 dose escalation study of ABO-101 in 6-9 patients A Natural History Study ...

CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the first ...

Researchers from the Boston University School of Public Health in the United States say there is no evidence to support a correlation between ABO blood group and the risk of infection with severe ...

Blood specimens of 534 Anglo-Indians (descendants of European-Indian miscegenation) of Delhi, Lucknow, Bombay and Poona were tested for ABO, MN, and with 5 Rh anti-sera. In general Anglo-Indians are ...

COPENHAGEN, DENMARK — Patients with non-O blood types are at significantly increased risk for venous thromboembolic and cardiovascular events, a study of 1.1 million blood donors confirms [1]. ABO ...

- ABO-101 was well tolerated with no serious adverse events or dose-limiting toxicities reported in the 28-days following dosing - Phase 1/2 redePHine study (NCT06839235) dose escalation ongoing with ...